Alabaster

Alabaster is a combination inhaler containing Formoterol and Beclometasone, used for respiratory conditions. It combines bronchodilation and anti-inflammatory effects for effective asthma and COPD management.

Alabaster is primarily used for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD). The Formoterol component helps to relax and open the airways, while Beclometasone reduces inflammation in the lungs. This combination is often prescribed for long-term control of symptoms such as wheezing, shortness of breath, and coughing.

Common effects of Alabaster may include a reduction in airway inflammation and improved breathing. Users might experience relief from symptoms like wheezing and shortness of breath. Some individuals may also notice an increase in energy levels due to better respiratory function.

Alabaster should be used as directed by a healthcare professional. It is important to follow the prescribed dosage and administration instructions. Patients with certain medical conditions, such as heart disease or diabetes, should discuss their use of Alabaster with their doctor. Regular monitoring may be required to ensure the medication's effectiveness and safety.

Alabaster may interact with other medications, including beta-blockers, diuretics, and certain antidepressants. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and other respiratory medications should be used with caution while using Alabaster.